sargramostim plasmid DNA melanoma vaccine adjuvant
Term · Oncology and biomedicine · MLC-T-ONC-016645
A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (a granulocyte macrophage-colony stimulating factor). Upon administration, expressed sargramostim may stimulate a cytotoxic T cell response enhancing the host immune response to a concomitantly administered melanoma vaccine.
| Identifier | MLC-T-ONC-016645 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | GM-CSF plasmid DNA melanoma vaccine adjuvant |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016645",
"term": "sargramostim plasmid DNA melanoma vaccine adjuvant",
"field": "Oncology and biomedicine",
"definition": "A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (a granulocyte macrophage-colony stimulating factor). Upon administration, expressed sargramostim may stimulate a cytotoxic T cell response enhancing the host immune response to a concomitantly administered melanoma vaccine.",
"synonyms": [
"GM-CSF plasmid DNA melanoma vaccine adjuvant"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/sargramostim-plasmid-dna-melanoma-vaccine-adjuvant/"
}
Record 14,693 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.